Web11 apr. 2024 · HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
HUTCHMED (China) Limited (HCM) Stock Price, News, Quote
Web11 apr. 2024 · HUTCHMED (Nasdaq/AIM: HCM; HKEX: 13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Web31 mrt. 2024 · See the latest HUTCHMED (China) Ltd stock price (XHKG:00013 ... Hong Kong, HKG. ... The formula for calculating dividend yield is to divide the annual dividend … tackle\u0027s ur
HUTCHMED Announces Pricing of Global Offering
WebHutchmed (china) share chat. The most active stock market forums in the UK. ... Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last … Web2 dagen geleden · Share Price Information for Hutchmed (HCM) Share Price is delayed by 15 minutes . Get Live Data. Share Price: 250.00. ... Hong Kong, Shanghai & Florham … Web17 nov. 2024 · HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China. HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 14, … tackle\u0027s vj